VANCOUVER, BC, May 22, 2024
/CNW/ -
TSX VENTURE COMPANIES
BULLETIN V2024-1525
CANADIAN NET REAL ESTATE INVESTMENT TRUST
("NET.UN")
BULLETIN TYPE: Notice of
Distribution
BULLETIN DATE: May 22. 2024
TSX Venture Tier 2
Company
The Issuer has advised of the following distributions:
Distribution per Unit: $0.02875
Payable Date: July 31, 2024; August 30,
2024 and September 30,
2024
Record Date: July 15, 2024;
August 15, 2024 and September 13, 2024
Ex-distribution Date: July 15, 2024;
August 15, 2024 and September 13, 2024 respectively
_______________________________________
BULLETIN V2024-1526
PUREBRED BRANDS INC. ("BRED")
[formerly COHO
COLLECTIVE KITCHENS INC. ("COHO")]
BULLETIN TYPE:
Name Change, Symbol Change
BULLETIN DATE:
May 22, 2024
TSX Venture
Tier 2 Company
Pursuant to a directors' resolution passed on April 3, 2024, the Company has changed its name
as follows. There is no consolidation of capital.
Effective at the opening Friday, May
24, 2024, the common shares of Purebred Brands Inc. will
commence trading on TSX Venture Exchange, and the common shares of
Coho Collective Kitchens Inc. will be delisted. The Company
is classified as a 'Manufacturing/Industrial' company.
Capitalization:
unlimited shares with no par value of which
115,783,402 shares are issued and outstanding
Escrow:
22,774,365 shares subject to escrow
Transfer
Agent:
Computershare Investor Services Inc.
Trading
Symbol:
BRED
(new)
CUSIP Number:
74624T107
(new)
_______________________________________
BULLETIN V2024-1527
COPPER ROAD RESOURCES INC. ("CRD")
BULLETIN TYPE: Resume Trading
BULLETIN DATE: May 22, 2024
TSX Venture Tier 2 Company
Further to TSX Venture Exchange (the "Exchange") bulletin dated
May 3, 2024, the Exchange has been
advised that Copper Road Resources Inc. (the "Company") has
completed the sale of the Copper Road Project (the "Disposition")
to Sterling Metals Corp. ("Sterling") and completed the
distribution of the Sterling common shares received as
consideration for the Disposition to its shareholders. In
accordance, effective at the open, Friday, May 24, 2024, trading in the Company's
shares will resume.
This resumption of trading does not constitute final acceptance
of the Exchange. The Exchange will issue a separate bulletin
confirming final acceptance on completion of certain final
acceptance conditions.
For further details, please refer to the news release dated
May 10, 2024.
_______________________________________
BULLETIN V2024-1528
HIVE DIGITAL TECHNOLOGIES LTD.
("HIVE.WT")
BULLETIN TYPE: Warrant
Expiry-Delist
BULLETIN DATE: May 22, 2024
TSX Venture Tier 2
Company
Effective at the opening, May 30,
2024, the Share Purchase Warrants of the Company will trade
for cash same day settlement. The Warrants expire May 30, 2024 and will therefore be halted at
Noon E.T. and delisted at the close
of business May 30, 2024.
TRADE DATES
May 30, 2024 - TO SETTLE –
May 30, 2024
The above is in compliance with Trading Rule C.2.18 – Expiry
Date:
Trading in the warrants shall be for cash same day settlement on
the expiry date. On the expiry date, trading shall cease at 12
o'clock noon E.T. and no transactions
shall take place thereafter except with permission of the
Exchange.
_______________________________________
BULLETIN V2024-1529
LSL PHARMA GROUP INC. ("LSL") ("LSL.DB")
BULLETIN
TYPE: New Listing-Debentures
BULLETIN DATE:
May 22, 2024
TSX Venture
Tier 2 Company
Effective at the opening on Friday,
May 24, 2024, the debentures of the Company will
commence trading on TSX Venture Exchange (the "Exchange").
The Company is classified as a "Pharmaceutical and medicine
manufacturing" company (NAICS: 32541).
Corporate
Jurisdiction:
Canada
Capitalization:
$3,288,000 Debentures are issued and
outstanding
Transfer
Agent:
TSX Trust Company
Trading
Symbol:
LSL.DB
CUSIP Number:
50190NAA2
Details of the Debentures: (Note: all capitalized
terms used below and not otherwise defined shall have the meanings
given to them in the Debenture Indenture)
|
Maturity Date:
|
October 31, 2028 (the
"Maturity Date")
|
|
|
|
Redemption:
|
Subject to regulatory
approval and subject to any provisions of the Debenture Indenture,
the Company at its option, shall have the right to redeem, either
in whole at any time or in part from time to time before the
Maturity Date by payment of money, the debentures at a price per
Debenture equal to: (i) 110% of the principal amount plus accrued
and unpaid interest if redeemed prior to November 1, 2027; (ii)
102% of the principal amount plus accrued and unpaid interest if
redeemed on or after November 1, 2027 , but prior to the Maturity
Date; or (iii) in the event redemption of the Debentures is
required to secure financing for a bona fide acquisition, (A) 105%
of the principal amount plus accrued and unpaid interest if
redeemed prior to November 1, 2024 , (B) 104% of the principal
amount plus accrued and unpaid interest if redeemed on or after
November 1, 2024 but prior to November 1, 2025, and (C) 102% of the
principal amount plus accrued and unpaid interest if redeemed on or
after November 1, 2025 but prior to the Maturity Date
(the "Redemption Price"). If partial redemption
ofdac5a the Debentures is carried out prior to the
Maturity Date, the Redemption Price shall only apply to that
portion of the principal amount of the Debentures that is being
redeemed.
|
|
|
|
If, at any time
following the date that is 24 months from November 1, 2023, for the
preceding 20 consecutive trading days (i) the daily volume weighted
average trading price of the Class A Shares on the Exchange is
greater than 175% of the Conversion Price; and (ii) the average
daily volume of the Class A Shares traded on the Exchange is no
less than the number obtained when dividing the number of shares
issued upon conversion of the total amount of Debentures
outstanding by twenty (20), LSL Pharma Group Inc. (the "Company")
will have the option to convert all of the principal amount
outstanding of the Debentures at the Conversion Price with at least
thirty (30) days' prior written notice.
|
|
|
|
Interest:
|
11% per annum (the
"Base Rate") payable in cash semi-annually on the last day of April
and October of each year with the first interest payment to be paid
on October 31, 2024 ("First Interest Payment Date"). Interest will
accrue from November 1, 2023 (the "Initial Closing Date") up to the
First Interest Payment Date at the Base Rate, compounding
semi-annually on the last day of April and October of each year
(the "Interest Period").
|
|
|
|
The annual interest
rate will be recalculated twice every year on April 30th and
October 31st of each year, starting April 30, 2025 (each an
"Interest Rate Review Date") until the Maturity Date, and shall be
equal to the Base Rate less 100 basis points (1.0%) for each
Business Objective (as defined below) achieved (the "Amended Base
Rate"). Upon achievement of a Business Objective (as defined
below), the Amended Base Rate will be effective as of the following
interest payment date of the Debentures (after April 30, 2025)
until the next interest payment date thereafter if Business
Objective 3 (as defined below) is achieved or until the Maturity
Date if a Business Objective 1 or 2 (as defined below) is
achieved.
|
|
|
|
Business Objectives
(each a "Business Objective"):
|
|
- Business Objective
1: the obtention by the Company of FDA approval for its
Steri-Med plant (one-time business objective);
- Business Objective
2: the completion by the Company of the acquisition of a business
which: 1) complements the Company's existing product offering
and/or creates synergies with the Company's existing business
operations and 2) generated a minimum of CAD$5.0 million in revenue
during the last twelve-month (12) period preceding the acquisition
(one- time business objective); or
- Business Objective
3: the Company generates a minimum of CAD$30 million of revenue
with a 20% EBITDA margin during the fiscal period preceding the
Interest Rate Review Date (annual business objective).With respect
to Business Objective 3, the Company's financial
performance and revenue shall be calculated based on its audited
financial statements and the Company's EBITDA margin shall be
calculated as EBITDA (not adjusted EBITDA), as calculated in its
audited financial statements, divided by its revenue (the "Business
Objective 3",and the "Business Objective 1 or 2" means the Business
Objective other than Business Objective 3)
|
|
|
|
Conversion:
|
Each Debenture will be
convertible in its entirety into common shares of the Company at
$0.70 per share, which are listed on the TSX Venture Exchange under
ticker symbol "LSL", at the option of the holder at any time prior
to the close of business (5:00 p.m. Eastern time) on the earlier
of: (i) the last Business Day immediately preceding the Maturity
Date of the Debenture, and (ii) the Redemption Date fixed for such
Debenture. The Debenture Indenture makes provision for the
adjustment of the Conversion Price in the events therein
specified.
|
|
|
|
Clearing and
Settlement:
|
The Debentures will
clear and settle through CDS.
|
|
|
|
Board Lot:
|
The Debentures are in
denominations of $10 and will trade in a board lot size of
$1,000 face value.
|
The first interest payment will be on October 31, 2024 in the amount of $113.025 per $1,000
principal amount of Debentures and will represent accrued interest
payable from and including November 1,
2023 to but excluding October 31,
2024.
For further information, please refer to the Exchange bulletin
dated May 3, 2024, the Company's news
release dated May 22, 2024, and
please consult the debenture indenture dated November 1, 2023 available on www.sedarplus.ca
(the "Debenture Indenture").
GROUPE LSL PHARMA INC. (« LSL ») (« LSL.DB »)
TYPE
DE BULLETIN : Nouvelle inscription - Débentures
DATE
DU BULLETIN : Le 22 mai 2024
Société du groupe 2 de
TSX Croissance
Les débentures de la société seront admises à la négociation de
la cote de la Bourse de croissance TSX (la « Bourse ») à
l'ouverture des affaires vendredi le 24 mai 2024. La société
est catégorisée dans le secteur de la « fabrication de produits
pharmaceutiques et de médicaments » (numéro de SCIAN : 32541)
Juridiction de la société
Canada
Capitalisation
3 288 000 $ de débentures sont émis et en circulation
Agent des transferts :
Compagnie TSX Trust
Symbole au téléscripteur :
LSL.DB
Numéro de CUSIP :
50190NAA2
Détails des débentures (Note : tous les termes utilisés
ci-dessous qui ne sont pas autrement définis, ont le sens qui leur
est accordé dans l'acte de débentures)
|
Date d'échéance :
|
31 octobre 2028 (la
« date d'échéance »)
|
|
|
|
Remboursement :
|
Sous réserve de
l'approbation réglementaire et de toute disposition de l'acte de
débentures, la société, à son gré, aura le droit de rembourser,
soit en totalité à tout moment, soit en partie de temps à autre
avant la date d'échéance (telle que définie ci-dessous) par
paiement en espèce, les débentures à un prix par débenture égal
à : (i) 110 % du capital plus les intérêts courus et
impayés si remboursés avant le 1 novembre 2027; (ii) 102 % du
montant en capital majoré des intérêts courus et impayés en cas de
remboursement le 1 novembre 2027 ou après, , mais avant la date
d'échéance; ou (iii) dans le cas où le remboursement des débentures
est requis pour garantir le financement d'une acquisition
véritable, (A) 105 % du capital plus les intérêts courus et impayés
en cas de remboursement avant le 1 novembre 2024, (B) 104 % du
montant en principal plus les intérêts courus et impayés en cas de
remboursement à compter du 1 novembre 2024, mais avant le
1 novembre 2025, et (C) 102 % du montant en capital
majoré des intérêts courus et impayés en cas de remboursement à
compter du 1 novembre 2025, mais avant la date d'échéance (le «
prix de remboursement »). Si le remboursement partiel des
débentures est effectué avant la date d'échéance, le prix de
remboursement s'appliquera uniquement à la partie du capital des
débentures qui est remboursée.
|
|
|
|
Si, à tout moment après
la date qui tombe 24 mois après le 1 novembre 2023, pendant les 20
jours de négociation à la bourse consécutifs précédents, (i) le
cours moyen pondéré en fonction du volume quotidien des actions de
catégorie A à la Bourse est supérieur à 175 % du prix de
conversion, et (ii) le volume quotidien moyen des actions de
catégorie A négociées à la Bourse n'est pas inférieur au nombre
obtenu en divisant par vingt (20) le nombre d'actions émises lors
de la conversion du montant total des débentures en circulation,
Groupe LSL Pharma Inc. (la « société » ) aura
l'option de convertir la totalité du capital des débentures en
circulation au prix de conversion, moyennant un préavis écrit d'au
moins trente (30) jours.
|
|
|
|
Taux d'intérêt :
|
11% par année (le
« taux de base »), payable en espèces semestriellement le
dernier jour d'avril et d'octobre de chaque année, le premier
paiement d'intérêt devant être effectué le 31 octobre 2024 («
première date de paiement d'intérêt »). Les intérêts courront à
partir du 1er novembre 2023 (la « date de clôture initiale »)
jusqu'à la première date de paiement d'intérêt au taux de base,
composés semestriellement le dernier jour d'avril et d'octobre de
chaque année (la « période d'intérêt »).
|
|
|
|
Le taux d'intérêt
annuel sera recalculé deux fois par an, le 30 avril et le 31
octobre de chaque année, à partir du 30 avril 2025 (chacune étant
une « date de révision du taux d'intérêt ») jusqu'à la date
d'échéance, et sera égal au taux de base moins 100 points de base
(1,0%) pour chaque objectif commercial (tel que défini ci-dessous)
atteint (le « taux de base modifié »). Lorsqu'un objectif
commercial est atteint, le taux de base modifié sera effectif à
partir de la date de paiement d'intérêts suivante des débentures
(après le 30 avril 2025) jusqu'à la prochaine date de paiement
d'intérêts par la suite si l'objectif commercial 3 (tel que défini
ci-dessous) est atteint ou jusqu'à la date d'échéance si l'objectif
commercial 1 ou 2 (tel que défini ci-dessous) est
atteint.
|
|
|
|
Objectifs commerciaux
(chacun étant un « objectif commercial ») :
|
|
- Objectif commercial
1 : l'obtention par la société de l'approbation de la FDA pour
son usine Steri-Med (objectif commercial ponctuel);
- Objectif commercial
2 : la réalisation par la société de l'acquisition d'une
entreprise qui : (1) complète l'offre de produits existante de la
société et/ou crée des synergies avec les opérations commerciales
existantes de la société ; et (2) a généré un minimum de 5,0 M$ CAD
de revenus au cours des douze (12) derniers mois précédant
l'acquisition (objectif commercial ponctuel); ou
- Objectif commercial
3 : la société génère un minimum de 30 M$ CAD de revenus avec
une marge du BAIIA de 20 % au cours de l'exercice financier
précédant la date de révision du taux d'intérêt (objectif
commercial annuel). En ce qui concerne l'objectif commercial 3, la
performance financière et le chiffre d'affaires de la société sont
calculés sur la base de ses états financiers audités et la marge
EBITDA de la société correspond à l'EBITDA (et non à l'EBITDA
ajusté), tel que calculé dans ses états financiers audités, divisé
par son chiffre d'affaires (l'« objectif commercial 3 »,
et l'« objectif commercial 1 ou 2 » désigne l'objectif
commercial autre que l'objectif commercial 3).
|
|
|
|
Conversion :
|
Chaque débentures sera
convertible dans son entièreté en action ordinaires de la société à
un prix de $0.70 par action, qui sont inscrites sur la Bourse de
croissance TSX sous le symbole « LSL », au gré du
porteur, à tout moment avant la fermeture des bureaux (17h00, heure
de l'Est) à la première des dates suivant : (i) le dernier
jour ouvrable précédant immédiatement la date d'échéance de la
débenture, et (ii) la date de remboursement fixée pour cette
débenture. L'acte de débentures prévoit l'ajustement du prix de
conversion dans les événements qui y sont précisés.
|
|
|
|
Compensation et
règlement :
|
Les débentures seront
compensées et réglées auprès de CDS.
|
|
|
|
Lot régulier :
|
Les débentures sont en
incréments de $10 et seront négociées par lots réguliers d'une
valeur nominale de 1 000 $.
|
Le premier paiement d'intérêts aura lieu le 31 octobre 2024 au
montant de 113,025 $ par tranche de 1 000 $ de capital des
débentures et représentera les intérêts courus payables à partir du
1er novembre 2023 inclusivement jusqu'au 31 octobre 2024
exclusivement.
Pour plus d'information, veuillez-vous référez au bulletin émis
par la Bourse le 3 mai 2024, au communiqué de presse émis par la
société le 22 mai 2024, et veuillez
consulter l'acte de débentures daté du 1er novembre 2023
disponible sur www.sedarplus.ca (l'« acte de
débentures »).
_______________________________________
BULLETIN V2024-1530
NAMSYS INC. ("CTZ")
BULLETIN TYPE:
Declaration of a Special Dividend
BULLETIN DATE:
May 22, 2024
TSX Venture
Tier 2 Company
The Issuer has declared the following special dividend:
Dividend per common share: $0.05
Payable Date: June 11, 2024
Record Date: May 29, 2024
Ex-dividend Date: May 29,
2024
_______________________________________
BULLETIN V2024-1531
NEXLIVING COMMUNITIES INC. ("NXLV")
BULLETIN
TYPE: Declaration of Dividend
BULLETIN DATE:
May 22, 2024
TSX Venture
Tier 2 Company
The Issuer has declared the following dividend:
Dividend per common share: $0.01
Payable Date: June 28, 2024
Record Date: June 07, 2024
Ex-dividend Date: June 07, 2024
_______________________________________
BULLETIN V2024-1532
SSC SECURITY SERVICES CORP. ("SECU")
BULLETIN
TYPE: Declaration of Dividend
BULLETIN DATE:
May 22, 2024
TSX Venture
Tier 1 Company
The Issuer has declared the following dividend:
Dividend per common share: $0.03
Payable Date: July 15, 2024
Record Date: June 30, 2024
Ex-dividend Date: June 28,
2024
_______________________________________
BULLETIN V2024-1533
STELLAR AFRICAGOLD INC. ("SPX")
BULLETIN
TYPE: Consolidation
BULLETIN DATE:
May 22, 2024
TSX Venture
Tier 2 Company
Pursuant to a resolution passed by the directors of the Company
on April 23, 2024, the Company has
consolidated its capital on a ten (10) old for one (1) new
basis. The name of the Company has not been
changed.
Effective at the opening May 24,
2024, the shares of Stellar AfricaGold Inc. will
commence trading on TSX Venture Exchange on a consolidated basis.
The Company is classified as a 'Gold and Silver Mining'
company.
Post - Consolidation
Capitalization:
Unlimited shares with no
par value of which
12,090,796 shares are issued and
outstanding
Escrow
Nil shares are subject to escrow
Transfer
Agent:
TSX Trust Company
Trading Symbol:
SPX
(UNCHANGED)
CUSIP Number:
85855B201
(NEW)
_______________________________________
BULLETIN V2024-1534
TOKENS.COM CORP. ("XBOT") ("XBOT.WT")
[formerly
Tokens.com Corp. ("COIN") ("COIN.WT")]
BULLETIN TYPE:
Symbol Change
BULLETIN DATE: May
22, 2024
TSX Venture Tier 2 Company
Effective at the opening, Friday, May
24, 2024, the trading symbol for the Company's common
shares will change from ("COIN") to ("XBOT"). In addition, the
trading symbol for the Company's warrants will change from
("COIN.WT") to ("XBOT.WT"). There is no change in the company's
name, no change in its CUSIP number and no consolidation of
capital. The Company is classified as a 'Internet Services - Data
Processing, Hosting & Related Services' company.
For more information, refer to the Company's news release dated
May 21, 2024.
_______________________________________
24/05/22 - TSX Venture Exchange
Bulletins
TSX VENTURE COMPANIES
BULLETIN V2024-1535
ELCORA ADVANCED MATERIALS CORP. ("ERA")
BULLETIN
TYPE: Private Placement-Non-Brokered, Convertible
Debenture
BULLETIN DATE: May
22, 2024
TSX Venture Tier 2 Company
TSX Venture Exchange has accepted for filing documentation with
respect to a Non-Brokered Private Placement announced on
May 16, 2024:
Convertible
Debenture:
$102,750
Conversion Price:
Convertible into 2,055,000 common
shares at a conversion price of $0.05
per share
Maturity
date:
September 27, 2024
Interest rate:
8% per
annum
Number of Placees:
1 placee
Insider / Pro Group
Participation:
Nil
Finder's
Fee:
Nil
The Company has confirmed closing of the Private Placement in a
news release dated May 16, 2024.
_______________________________________
BULLETIN V2024-1536
FOKUS MINING CORPORATION ("FKM")
BULLETIN
TYPE: Private Placement-Non-Brokered
BULLETIN
DATE: May 22,
2024
TSX Venture Tier 2 Company
Further to the TSX Venture Exchange (the "Exchange") bulletin
dated May 16, 2024, the Exchange has
accepted for filing documentation with respect to the remaining
Non-Brokered Private Placement announced on December 4, 2023:
Number of
Shares:
1,500,000 common shares
Purchase Price:
$0.04 per common share
Warrants:
1,500,000 common share purchase warrants to purchase
1,500,000 common shares
Warrant Exercise Price:
$0.06 per common share for a period of 48 months
Number of
Placees:
1 placee
Insider / Pro Group
Participation:
Nil
Finder's Fee:
As disclosed in the Exchange bulletin dated May 16, 2024, a cash finder's fee
of
$1,880 was paid in respect of this
entire private placement.
The Company issued a news release on December 22, 2023 confirming closing of the
private placement.
Note that in certain circumstances the Exchange may later extend
the expiry date of the warrants, if they are less than the maximum
permitted term.
CORPORATION MINIÈRE FOKUS (« FKM »)
TYPE DE
BULLETIN : Placement privé sans l'entremise d'un
courtier
DATE DU BULLETIN : Le 22 mai
2024
Société du groupe 2 de TSX Croissance
Suite au bulletin émis par la Bourse de Croissance TSX (la
« Bourse ») le 16 mai 2024, la Bourse a accepté le dépôt
de la documentation de la société en vertu du restant d'un
placement privé sans l'entremise d'un courtier annoncé le 4
décembre 2023 :
Nombre d'actions :
1 500 000 actions ordinaires
Prix :
0,04 $ par action ordinaire
Bons de souscription :
1 500 000 bons de souscription permettant de souscrire à 1
500 000 actions ordinaires
Prix d'exercice des bons : 0,06 $ par
action ordinaire pour une période de 48 mois
Nombre de souscripteurs : 1
souscripteur
Participation d'initiés /
Groupe Pro
:
Aucun
Honoraire d'intermédiation : Tel que divulgué
dans le bulletin émis par la Bourse le 16 mai 2024, un montant
de 1 880 $ en
espèces a été payé comme honoraire d'intermédiation en vertu
de l'ensemble de ce
placement privé.
La société a confirmé la clôture du placement privé dans un
communiqué de presse daté du 22 décembre 2023.
Notez que dans certaines circonstances, la Bourse peut ensuite
prolonger la durée des bons de souscription, s'ils sont inférieurs
à la durée maximale autorisée.
_______________________________________
BULLETIN V2024-1537
KOOTENAY SILVER INC. ("KTN")
BULLETIN TYPE:
Prospectus-Unit Offering
BULLETIN DATE: May 22, 2024
TSX Venture Tier 1
Company
Effective April 25, 2024,
the Company's Offering (as defined below) filed pursuant to the
Prospectus Supplement dated April 17,
2024, to the Short Form Base Shelf Prospectus dated
March 27, 2024, was filed with and
accepted by TSX Venture Exchange. The Short Form Base Shelf
Prospectus was filed with the British Columbia Securities
Commission and the authorities of all provinces of
Canada.
TSX Venture Exchange has been advised that closing occurred on
April 25, 2024, for gross proceeds
of C$ 10,350,000.
Agents:
Red Cloud Securities Inc. and Research Capital
Corporation
Offering:
9,241,071 units. Each unit consists of one common share in the
capital of the
company and one-half of
one common share purchase warrant.
Unit Price:
$1.12 per unit
Warrant Exercise Price/Term: $1.68 per share/ till April 25, 2026
Over-allotment Option:
The Agents were granted an over-allotment option exercisable
on closing to
purchase up to an
additional 1,205,357 Units at a price of $1.12 per Over-
Allotment Share
which was exercised at the closing and included above.
For further information, please reference the Company's Short
Form Base Shelf Prospectus dated March 27,
2024, and news release dated April
25, 2024.
_______________________________________
BULLETIN V2024-1538
MADORO METALS CORP. ("MDM")
BULLETIN TYPE:
Private Placement, Non-Brokered Private
Placement
BULLETIN DATE: May
22, 2024
TSX Venture Tier 2 Company
Financing
Type:
Non-Brokered Private Placement
Gross Proceeds:
$305,000.00
Offering:
15,250,000 common shares with 7,625,000 warrants
attached
Offering Price:
$0.02 per common
share
Warrant Exercise Terms:
$0.05 per common share for a two-year period
|
Non-Cash
Commissions:
|
|
Shares
|
Warrants
|
|
|
N/A
|
N/A
|
Public Disclosure:
Refer to the company's news releases dated May 9, 2024, May 14,
2024.
_______________________________________
BULLETIN V2024-1539
P2 GOLD INC. ("PGLD")
BULLETIN TYPE:
Halt
BULLETIN DATE: May 22,
2024
TSX Venture Tier 2 Company
Effective at 6:06 a.m. PST,
May 22, 2024, trading in the shares
of the Company was halted, pending news; this regulatory halt is
imposed by Investment Industry Regulatory Organization of
Canada, the Market Regulator of
the Exchange pursuant to the provisions of Section 10.9(1) of the
Universal Market Integrity Rules.
_______________________________________
BULLETIN V2024-1540
P2 GOLD INC. ("PGLD")
BULLETIN TYPE:
Resume Trading
BULLETIN DATE: May 22, 2024
TSX Venture Tier 2
Company
Effective at 7:00 a.m. PST,
May 22, 2024, shares of the Company
resumed trading, an announcement having been made.
_______________________________________
BULLETIN V2024-1541
PASOFINO GOLD LIMITED ("VEIN")
BULLETIN TYPE:
Private Placement-Non-Brokered
BULLETIN DATE:
May 22, 2024
TSX Venture
Tier 2 Company
TSX Venture Exchange has accepted for filing documentation with
respect to a Non-Brokered Private Placement announced on
January 22, 2024:
Number of
Shares:
6,291,000 common shares
Purchase
Price:
$0.50 per common share
Warrants:
3,145,500 share purchase warrants to purchase 3,145,500
shares
Warrant Exercise Price:
$0.65 for an 18–month period
Number of
Placees:
2 placees
Insider / Pro Group Participation:
|
|
|
|
Placees
|
# of Placee
(s)
|
Aggregate # of
Shares
|
|
|
|
|
Aggregate Existing
Insider
Involvement:
|
2
|
6,291,000
|
|
Aggregate Pro Group
Involvement:
|
N/A
|
N/A
|
|
|
|
|
Aggregate Cash
Amount
|
Aggregate
#
of
Shares
|
Aggregate
#
of
Warrants
|
|
Finder's
Fee:
|
N/A
|
N/A
|
N/A
|
The Company issued a news release on February 9, 2024 confirming closing of the
private placement. [Note that in certain circumstances the
Exchange may later extend the expiry date of the warrants, if they
are less than the maximum permitted term.]
_______________________________________
BULLETIN V2024-1542
SILVER NORTH RESOURCES LTD. ("SNAG")
BULLETIN
TYPE: Property-Asset or Share Purchase
Agreement
BULLETIN DATE: May
22, 2024
TSX Venture Tier 2 Company
TSX Venture Exchange has accepted for filing the documentation
relating to an option agreement dated May
09, 2024, between arm's length parties (the "Optionor") and
Silver North Resources Ltd. (the "Company"). Pursuant to the
agreement, the company wishes to acquire 100% interest in the MR,
MFW, and Veronia Properties in Southern Yukon territory from the
Optionor over a period of 4 years.
Pursuant to the Agreement, the Company shall make staged cash
payments amounting $102,000 over four
years and staged share payments of 1.56 million common shares over
four years to earn a 100-per-cent interest in the GDR project,
In addition, the Company may, upon payment to the Optionor a
$2 million, reduce the royalty
payable under the net smelter returns royalty (NSR) by 0.9%.
For further information, please refer to the Company's press
release dated May 14, 2024.
_______________________________________
BULLETIN V2024-1543
UPSTART INVESTMENTS INC. ("UPT.P")
BULLETIN
TYPE: Halt
BULLETIN DATE: May 22, 2024
TSX Venture Tier 2
Company
Effective at 6:22 a.m. PST,
May 22, 2024, trading in the shares
of the Company was halted, pending news; this regulatory halt is
imposed by Investment Industry Regulatory Organization of
Canada, the Market Regulator of
the Exchange pursuant to the provisions of Section 10.9(1) of the
Universal Market Integrity Rules.
_______________________________________
BULLETIN V2024-1544
VORTEX METALS INC. ("VMS")
BULLETIN TYPE:
Property-Asset or Share Purchase Agreement
BULLETIN
DATE: May 22,
2024
TSX Venture Tier 2 Company
TSX Venture Exchange has accepted for filing documentation with
respect to an arm's length mineral property option agreement (the
"Agreement") between Vortex Metals Inc. (the "Company") and two
arm's length parties (together "the Optionors"). Pursuant to the
Agreement, the Company will have an option to acquire an 80%
interest in in the Illapel Copper Project, consisting of certain
mineral claims located in Illapel, Choapa Province, Chile (the "Property"). On exercise of the
option, the Property will be held in a joint venture company (the
"JV"), between the Company and the Optionors.
Pursuant to the terms of the Agreement, the Company may earn up
to an initial 60% interest (the "Initial Option") in the Property
by paying to the Optionors: (i) issue an aggregate of 23,000,000
common shares over a six (6) year period; (ii) pay an aggregate of
$1,100,000 in cash over a four (4)
year period; (iii) incur an aggregate of $10,000,000 in exploration expenditures on the
Property over a five (5) year period; and (iv) completing a
Pre-Feasibility Study on the Property by the 6th
anniversary of the Agreement, which can be extended for another
year provided the Company pays an additional $200,000 to the Optionors by the 5th
anniversary of the Agreement. In addition, and as part of the
Initial Option, starting six (6) months from the closing date of
the Agreement, the Company is required to pay an Optionor
$4,500 in monthly contribution
(subject to a maximum of up to $226,000) to settle an existing debt.
Additionally, on exercise of the Initial Option, the Optionors
will retain a 2.5% net smelter returns ("NSR") on the Property. The
Company will have the option to buy back at any time 0.5% of such
NSR for USD$1,750,000 payable in
cash.
Upon exercise of the Initial Option, the Company will have 5
years from such date to acquire an additional 20% interest (the
"Second Option") within in the Property by completing (i) a
feasibility study on the Property or (ii) a future financing for
the construction of the Property.
Further, in connection with the acquisition an arms-length
finder may receive $47,500 in cash
and up to 987,500 Common Shares, payable in stages and in alignment
with the option exercise consideration paid by the Company.
For further details, please refer to the Company's news release
dated June 27, 2023, November 20, 2023, November 27, 2023, May 1,
2024 and May 21, 2024.
_______________________________________
BULLETIN V2024-1545
ZONTE METALS INC. ("ZON")
BULLETIN TYPE:
Private Placement-Non-Brokered
BULLETIN DATE:
May 22, 2024
TSX Venture
Tier 2 Company
TSX Venture Exchange has accepted for filing documentation with
respect to a Non-Brokered Private Placement announced on
May 1, 2024:
Number of
Shares:
1,705,000 common shares and
2,982,220
flow-through shares
Purchase
Price:
$0.08 per common share and
$0.09 per flow-through share
Warrants:
1,705,000 common share purchase warrants to purchase 1,705,000
common shares and
2,982,220
flow-through share purchase warrants to purchase 2,982,220 common
shares
Warrant Exercise Price:
$0.11 per common share purchase
warrant share until May 3, 2026
and
$0.15 per flow-through share purchase warrant
share until May 3, 2026
Number of Placees:
11 placees
Insider / Pro Group Participation:
|
Placees
|
# of Placee
(s)
|
Aggregate # of
Shares
|
|
|
|
|
Aggregate Existing
Insider
Involvement:
|
1
|
200,000
flow-through
shares and 100,000
common shares
|
|
Aggregate Pro Group
Involvement:
|
N/A
|
N/A
|
|
|
|
|
Aggregate Cash
Amount ($)
|
Aggregate
#
of
Shares
|
Aggregate
#
of
Warrants
|
|
Finder's
Fee:
|
$28,672
|
N/A
|
330,578 finder's
warrants
|
Finder's Warrants Terms: Each finder's warrant entitles the
holder to purchase one common share at the price of $0.18 until November 3,
2025.
The Company issued news releases on May
14, 2024 and May 17, 2024
confirming closing of the private placement.
Note that in certain circumstances the Exchange may later extend
the expiry date of the warrants, if they are less than the maximum
permitted term.
_______________________________________
NEX COMPANY:
BULLETIN V2024-1546
HORIZON PETROLEUM LTD. ("HPL.H")
BULLETIN
TYPE: Private Placement-Non-Brokered
BULLETIN
DATE: May 22,
2024
NEX Company
TSX Venture Exchange has accepted for filing documentation with
respect to a Non-Brokered Private Placement announced on
May 1, 2024:
Number of
Shares:
1,400,000 shares
Purchase
Price:
$0.05 per share
Warrants:
1,400,000 share purchase warrants to purchase 1,400,000 shares
Warrant Exercise Price:
$0.075 for a one-year period
Number of
Placees:
2 placees
|
Insider / Pro Group
Participation:
|
|
|
|
|
|
|
Placees
|
# of Placee
(s)
|
Aggregate # of
Shares
|
|
|
|
|
Aggregate Existing
Insider
Involvement:
|
N/A
|
N/A
|
|
Aggregate Pro Group
Involvement:
|
N/A
|
N/A
|
|
|
|
|
Aggregate Cash
Amount
|
Aggregate
#
of
Shares
|
Aggregate
#
of
Warrants
|
|
Finder's
Fee:
|
N/A
|
N/A
|
N/A
|
The Company issued a news releases on May
21, 2024 confirming closing of the private
placement.
Note that in certain circumstances the Exchange may later extend
the expiry date of the warrants, if they are less than the maximum
permitted term.
_______________________________________
SOURCE TSX Venture Exchange